µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© [&x9<f6
BK$y>=
`
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© [4)Oi-_Y>
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© W4^L_p>Tm^
1.Co-stimulators (or co-stimulating molecules) (?FH`<
2.NK-kB 86&M Zdv6
3.Immunoglobulin superfamily STKL
4.antigen-presenting cell (APC) iL/c^(1
5.death domain | /.J{=E0K
6.CCR and CXCR 2"/MM2s
7.Lectin (or mitogen) tV}!_
8.Clusters of differentiation, CD) sXLW';Fz
9.B7 family "ra$x2|=}
10.Cytotoxic T lymphocyte, CTL) WMbkKC.{J
11.IL-15 and IL-15 receptor (IL-15R) ,H7X_KbFD4
12.MHC restriction dQ:,pe7A
13.Affinity-chromatography ,p2UshOmd
14.Cyctosprin A, CsA lg%fjBY
15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
"Ih3
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 4jT6h9%
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 UmKE]1Yw4r
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ S
?Zh#`(*
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ $
QbJT`,mr
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© LKN7Lkl
ÃâÒßѧרҵ£º kBUkE-~
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ )k<cd.MX
Ïû»¯ÄÚ¿Æ£º q~`hn(S
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ HcRw9,I'
ѪҺ²¡Ñ§×¨Òµ£º (3e.q'
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿